Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

Jun 10 • 04:00PM ET

471.32

-5.57 -1.17 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: BBIO VKTX BMRN EXEL INCY KRYS ALNY RARE REGN VRTX

| Held by: VTI VB IWM VBK VXF XBI IBB IWO VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	5.91%	Shs Outstand	23.04M	Perf Week	-3.45%
Market Cap	10.87B	Forward P/E	44.71	EPS next Y	10.54	Insider Trans	-7.26%	Shs Float	21.69M	Perf Month	-5.17%
Enterprise Value	10.40B	PEG	-	EPS next Q	-2.38	Inst Own	105.25%	Short Float	17.63%	Perf Quarter	9.22%
Income	-309.44M	P/S	9.60	EPS this Y	49.05%	Inst Trans	2.68%	Short Ratio	12.26	Perf Half Y	-17.10%
Sales	1.13B	P/B	19.98	EPS next Y	260.99%	ROA	-27.83%	Short Interest	3.82M	Perf YTD	-19.06%
Book/sh	23.59	P/C	13.29	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -23.36%	Perf Year	66.95%
Cash/sh	35.48	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	275.00 71.39%	Perf 3Y	77.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	3.13% 4.13%	Perf 5Y	341.27%
Dividend TTM	-	EV/Sales	9.18	EPS Y/Y TTM	29.06%	Oper. Margin	-27.68%	ATR (14)	20.69	Perf 10Y	3735.46%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	41.14	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	-6.14%	Beta	-1.02	Target Price	679.33
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	-8.28%	Rel Volume	0.92	Prev Close	476.89
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	-4.10%	Avg Volume	311.80K	Price	471.32
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	287,530	Change	-1.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)